Table 2.
Univariate and multivariate survival analysis.
| Clinical factors | Event-free survival | Overall survival | ||||
|---|---|---|---|---|---|---|
| Univariate | Univariate | Multivariate | ||||
| p | HR (%95 CI) | p | HR (%95 CI) | p | HR (%95 CI) | |
| Gender (male) | 0.702 | 0.834 (0.329-2.115) | 0.200 | 1.757 (0.743-4.159) | — | — |
| Age (>50) | 0.848 | 0.911 (0.351-2.362) | 0.159 | 1.817 (0.792-4.167) | — | — |
| WBC (>100∗109/l) | 0.218 | 0.036 (0.000-7.056) | 0.820 | 0.890 (0.325-2.435) | — | — |
| BM blasts (>50%) | 0.146 | 0.494 (0.191-1.278) | 0.922 | 0.960 (0.422-2.186) | — | — |
| Risk stratification (poor) | 0.388 | 1.383 (0.662-2.889) | 0.395 | 1.407 (0.640-3.094) | — | — |
| CLL-1 (<59%) | 0.061 | 2.423 (0.960-6.111) | 0.019 | 2.738 (1.183-6.339) | 0.045 | 2.815 (1.021-7.758) |
| No CR after cycle 1 | 0.002 | 4.332 (1.687-11.119) | <0.001 | 7.483 (2.571-21.780) | 0.001 | 6.773 (2.228-20.587) |
HR: hazard ratio; CI: confidence interval; WBC: white blood cells; BM: bone marrow; CR: complete response.